Literature DB >> 7913247

Autoantibodies against ganglioside GM3 represent a portion of anti-lymphocyte antibodies in AIDS patients.

T Griggi1, R Bauer, T Garofalo, S Kukel, L Lenti, A P Massetti, C Müller, M Sorice, G M Pontieri.   

Abstract

In this study we analysed the relationship between anti-lymphocytic ganglioside antibodies and anti-lymphocyte antibodies in AIDS patients. Anti-lymphocytic ganglioside antibodies were detected by thin layer chromatography (TLC) immunostaining; three colour flow cytometry was used to analyse circulating antibodies against different lymphocyte subsets. Anti-lymphocytic ganglioside antibodies were detected in 23 out of 49 AIDS patients sera (46.9%). All positive sera reacted selectively with the GM3 comigrating band from AIDS lymphocytes. Twenty two out of the 23 anti-lymphocytic GM3 positive sera also had antibodies against CD4+T cells, versus 17/26 anti-GM3 negative. Furthermore, patients with lymphocytic GM3 antibodies showed a significantly higher antibody reactivity against CD4+ T cells than patients in which these antibodies were not detected. The absorption tests revealed that preincubation of positive sera with GM3 was followed by a decrease in the reaction with target lymphocytes. These findings suggest that anti-GM3 antibodies are a portion, but not the majority, of antibodies reacting with CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913247     DOI: 10.1111/j.1365-3083.1994.tb03436.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Authors:  Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

2.  Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis.

Authors:  Peter I Lobo; Kailo H Schlegal; John Vengal; Mark D Okusa; Hong Pei
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

3.  Cerebrospinal fluid antiganglioside antibodies in patients with AIDS.

Authors:  M Sorice; T Griggi; A Circella; G Nicodemo; M Ciardi; C M Mastroianni; L Lenti; F Sorice
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

4.  Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.

Authors:  Jia-Jun Liao; Mei-Chuan Huang; Katharine Fast; Katherine Gundling; Mahesh Yadav; James R Van Brocklyn; Matthias R Wabl; Edward J Goetzl
Journal:  FASEB J       Date:  2009-01-21       Impact factor: 5.191

Review 5.  Implications for lipids during replication of enveloped viruses.

Authors:  Robin B Chan; Lukas Tanner; Markus R Wenk
Journal:  Chem Phys Lipids       Date:  2010-03-15       Impact factor: 3.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.